Advanced Asset Management Advisors’s Regeneron Pharmaceuticals REGN Stock Holding History

Advanced Asset Management Advisors’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-3,400	Closed	-$1.4M	–	102
2019 Q1	$1.4M	Hold	3,400	–	–	0.5%	54
2018 Q4	$1.27M	Hold	3,400	–	–	0.41%	62
2018 Q3	$1.37M	Hold	3,400	–	–	0.5%	41
2018 Q2	$1.17M	Hold	3,400	–	–	0.38%	57
2018 Q1	$1.17M	Hold	3,400	–	–	0.39%	54
2017 Q4	$1.28M	Buy	+3,400	New	+$1.38M	0.42%	51

Other funds holding REGN

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Polen Capital Management Boca Raton, Florida $14.5B AUM 5.7% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Advanced Asset Management Advisors's REGN Position: Q2 2019 in Review

Advanced Asset Management Advisors sold out of Regeneron Pharmaceuticals (REGN) in Q2 2019, closing a stake of 3,400 shares — an estimated $1.4M sold.

Advanced Asset Management Advisors first reported a position in REGN in Q4 2017 and held it in 6 quarters. The position peaked at $1.4M in Q1 2019. 658 funds tracked by Wall St. Rank hold REGN as of Q2 2019.

Advanced Asset Management Advisors reported no remaining Regeneron Pharmaceuticals position as of Q2 2019 after selling out during the quarter.
Advanced Asset Management Advisors sold 3,400 Regeneron Pharmaceuticals shares in Q2 2019, an estimated $1.4M.
Advanced Asset Management Advisors first reported a position in Regeneron Pharmaceuticals in Q4 2017 and held it in 6 quarters.
Advanced Asset Management Advisors's Regeneron Pharmaceuticals position peaked at $1.4M in Q1 2019.
658 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2019.

Based on Advanced Asset Management Advisors's 13F filing for Q2 2019, filed 2 Aug 2019.